Analystreport

Adaptive Biotechnologies Corporation (NASDAQ: ADPT) had its "buy" rating re-affirmed by analysts at BTIG Research. They now have a $46.00 price target on the stock.

Adaptive Biotechnologies Corporation  (ADPT) 
Last adaptive biotechnologies corporation earnings: 2/26 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: adhc.com